Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyerga, a biological response modifier enhancing T-lymphocyte-dependent responses

G de Ojeda1, R Diez-Orejas, P Portolés

  • 1Centro de Investigaciones Biológicas, C.S.I.C., Madrid, Spain.

Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Injectable mesoporous bioactive nanoparticles regenerate bone tissue under osteoporosis conditions.

Acta biomaterialia·2022
Same author

Response of RAW 264.7 and J774A.1 macrophages to particles and nanoparticles of a mesoporous bioactive glass: A comparative study.

Colloids and surfaces. B, Biointerfaces·2021
Same author

Effects of mesoporous SiO<sub>2</sub>-CaO nanospheres on the murine peritoneal macrophages/Candidaalbicans interface.

International immunopharmacology·2021
Same author

Effects of nanocrystalline hydroxyapatites on macrophage polarization.

Journal of materials chemistry. B·2020
Same author

Silicon substituted hydroxyapatite/VEGF scaffolds stimulate bone regeneration in osteoporotic sheep.

Acta biomaterialia·2019
Same author

Synergistic effect of Si-hydroxyapatite coating and VEGF adsorption on Ti6Al4V-ELI scaffolds for bone regeneration in an osteoporotic bone environment.

Acta biomaterialia·2018

Porcine spleen peptides enhance immune function in mice by boosting lymphokine secretion and cytotoxic T-cell generation, supporting their use in cancer therapy. This study investigated the mechanism of these biological response modifiers.

Area of Science:

  • Immunology
  • Cancer Biology
  • Pharmacology

Background:

  • Biological response modifiers are used in cancer therapy to enhance immune function.
  • The precise mechanisms of action for many biological response modifiers remain unclear.
  • Porcine low-molecular-weight spleen peptides are utilized in supportive cancer care.

Purpose of the Study:

  • To investigate the effects of porcine low-molecular-weight spleen peptides on lymphoid cell populations and function in mice.
  • To elucidate the immunological mechanisms underlying the supportive role of these peptides in cancer therapy.

Main Methods:

  • Mice were treated intraperitoneally (i.p.) with 0.5 micrograms of peptides per kilogram of body weight daily for 14 consecutive days.
  • Lymphokine secretion and the generation of cytotoxic T-cells were measured.

Related Experiment Videos

  • Cell counts and the percentage of cells expressing functional surface markers in secondary lymphoid organs were analyzed.

    • Main Results:

    • Treatment with porcine spleen peptides significantly enhanced lymphokine secretion compared to controls.
    • The generation of cytotoxic T-cells was also significantly increased following peptide treatment.
    • No significant changes were observed in the total number of lymphoid cells or the percentage of cells expressing functional surface markers in secondary lymphoid organs.

    Conclusions:

    • Porcine low-molecular-weight spleen peptides can enhance key immune functions relevant to cancer therapy, specifically lymphokine secretion and cytotoxic T-cell activity.
    • The observed immunomodulatory effects occur without altering the overall cellularity or surface marker expression in lymphoid organs.
    • These findings provide mechanistic insights into the supportive role of porcine spleen peptides in cancer treatment.